G

Gushengtang Holdings Ltd
HKEX:2273

Watchlist Manager
Gushengtang Holdings Ltd
HKEX:2273
Watchlist
Price: 27.4 HKD -6.32% Market Closed
Market Cap: 6.6B HKD
Have any thoughts about
Gushengtang Holdings Ltd?
Write Note

Gushengtang Holdings Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gushengtang Holdings Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
G
Gushengtang Holdings Ltd
HKEX:2273
Cash & Cash Equivalents
ÂĄ1.3B
CAGR 3-Years
73%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Cash & Cash Equivalents
ÂĄ1.8B
CAGR 3-Years
-2%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Cash & Cash Equivalents
ÂĄ622.8m
CAGR 3-Years
-16%
CAGR 5-Years
9%
CAGR 10-Years
9%
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Cash & Cash Equivalents
ÂĄ4.6B
CAGR 3-Years
-10%
CAGR 5-Years
-1%
CAGR 10-Years
17%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Cash & Cash Equivalents
ÂĄ1.8B
CAGR 3-Years
12%
CAGR 5-Years
5%
CAGR 10-Years
26%
Jiangxi Rimag Group Co Ltd
HKEX:2522
Cash & Cash Equivalents
ÂĄ188.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Gushengtang Holdings Ltd
Glance View

Market Cap
6.7B HKD
Industry
Health Care

Gushengtang Holdings Ltd. has woven itself into the fabric of China's healthcare system by focusing on traditional Chinese medicine (TCM), an industry deeply embedded in the nation's culture and ethos. The company operates a network of clinics that provide an array of services, from herbal medicine consultations to acupuncture treatments, leveraging China's growing demand for holistic healthcare solutions. By embracing both traditional practices and modern healthcare technologies, Gushengtang has positioned itself as a key player in delivering health services that resonate with a significant portion of the Chinese population who seek alternatives to Western medicine. Revenue streams for Gushengtang are multifaceted. The company earns primarily through the fees charged for consultations and treatments offered at its clinics, while also generating income from the sale of TCM products. Furthermore, by cultivating partnerships with health institutions and expanding its franchise network, Gushengtang enhances its reach and scalability. The integration of technology has allowed the firm to streamline operations and offer additional services like telemedicine, adapting to the digital shift in healthcare and tapping into the broader wellness market. This diversified approach not only fortifies its market position but ensures a steady flow of revenue in a competitive industry.

Intrinsic Value
70.31 HKD
Undervaluation 61%
Intrinsic Value
Price
G

See Also

What is Gushengtang Holdings Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.3B CNY

Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Cash & Cash Equivalents amounts to 1.3B CNY.

What is Gushengtang Holdings Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
70%

Over the last year, the Cash & Cash Equivalents growth was 31%. The average annual Cash & Cash Equivalents growth rates for Gushengtang Holdings Ltd have been 73% over the past three years , 70% over the past five years .

Back to Top